Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.
about
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerRadio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsPrognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerScavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyTumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophagesA functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradationInflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.Effect on proliferation and apoptosis of retinoblastoma cell by RNA inhibiting high mobility group protein box-1 expression.Clinical significance of SLP-2 in hepatocellular carcinoma tissues and its regulation in cancer cell proliferation, migration, and EMT.Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
P2860
Q26746478-651FAC12-3157-43FD-B837-F7DB8668D73EQ26774902-C141B2AF-E47C-4E98-86AE-209CB7F2B563Q26779221-635C52BD-4FA9-4A71-ABFA-B7A45A5E0E59Q26795466-3D1C8AB3-1F12-48DD-844D-F3B0A4D82C22Q26799114-41CCB482-841F-4799-80E5-14FAC69E4888Q27325462-2DD31162-218D-49A9-A645-AF5F18C8BF06Q33798500-714BEE06-7F84-4A25-B418-289C0CC95328Q35835242-2B0E506F-C73E-4DBD-9201-DD6E0BC92918Q39294665-F4B6973D-05B5-4F26-B610-2CE8371E6694Q41191215-CE250A5B-CD43-459B-B9D0-35F67AA280F8Q42364459-776371FE-31A2-4EEB-A65F-07A271ACCF89Q55284109-96CDDEEE-B92D-41DB-81FA-D33CAB626FE6Q55307923-BCBCB8C4-31A5-41CE-A4D9-8E14623BBF6D
P2860
Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Co-expression of RAGE and HMGB ...... nt outcome of prostate cancer.
@ast
Co-expression of RAGE and HMGB ...... nt outcome of prostate cancer.
@en
type
label
Co-expression of RAGE and HMGB ...... nt outcome of prostate cancer.
@ast
Co-expression of RAGE and HMGB ...... nt outcome of prostate cancer.
@en
prefLabel
Co-expression of RAGE and HMGB ...... nt outcome of prostate cancer.
@ast
Co-expression of RAGE and HMGB ...... nt outcome of prostate cancer.
@en
P2093
P2860
P1476
Co-expression of RAGE and HMGB ...... nt outcome of prostate cancer.
@en
P2093
Chu-Biao Zhao
Da-Yong Zheng
Ji-Ming Bao
Shan-Chao Zhao
Xin-Hua Zhou
Yong-Jie Lu
P2860
P304
P577
2014-07-16T00:00:00Z